Literature DB >> 9832139

Coordinate expression of the vesicular acetylcholine transporter and choline acetyltransferase following septohippocampal pathway lesions.

M L Gilmor1, S E Counts, R G Wiley, A I Levey.   

Abstract

The gene for the vesicular acetylcholine transporter (VAChT) was recently cloned and found to be located within a 5' noncoding intron of the gene for choline acetyltransferase (ChAT). There appear to be several shared and unique promoters for each gene, suggesting that control of expression of these two genes can be either coordinated or independent. Two lesions, axotomy and immunotoxin, directed at the well defined septohippocampal cholinergic pathway were used to determine VAChT and ChAT protein expression in the degenerating terminal fields in the hippocampus and the cell bodies of the medial septum nucleus after injury. Two weeks after lesioning, decreases of up to 90% in VAChT were found in the affected hippocampus by immunoblotting and immunocytochemistry, similar to ChAT activity. The number of VAChT- and ChAT-immunopositive neurons in the medial septum decreased by up to 95%. Eight weeks following axotomy, the number of VAChT- and ChAT-immunopositive neurons had increased to almost 50% in fimbria-fornix-lesioned animals, indicating coordinate reexpression of both cholinergic markers in recovered neurons. There was no recovery of either VAChT or ChAT immunoreactivity after the irreversible immunotoxin lesions. Thus, with use of immunological techniques, there appears to be coordinate expression of VAChT and ChAT in the septohippocampal pathway following either unilateral fimbria-fornix or bilateral immunotoxin lesion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832139     DOI: 10.1046/j.1471-4159.1998.71062411.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

Review 2.  The cholinergic neuronal phenotype in Alzheimer's disease.

Authors:  J K Blusztajn; B Berse
Journal:  Metab Brain Dis       Date:  2000-03       Impact factor: 3.584

3.  BMP9 protects septal neurons from axotomy-evoked loss of cholinergic phenotype.

Authors:  Ignacio Lopez-Coviella; Tiffany J Mellott; Aletta C Schnitzler; Jan K Blusztajn
Journal:  PLoS One       Date:  2011-06-13       Impact factor: 3.240

4.  Intrinsic Cholinergic Neurons in the Hippocampus: Fact or Artifact?

Authors:  Jan Krzysztof Blusztajn; Jasmine Rinnofner
Journal:  Front Synaptic Neurosci       Date:  2016-03-10

5.  Intermittent vs Continuous Administration of Nerve Growth Factor to Injured Medial Septal Cholinergic Neurons in Rat Basal Forebrain.

Authors:  Kenneth E Miller; Gregory E Frierdich; Robert H Dillard; Robert H Soriano; Dikla G Roufa
Journal:  Neurosci Med       Date:  2014-04-30

6.  Reduction of acetylcholine in the hippocampus of hippocampal cholinergic neurostimulating peptide precursor protein knockout mice.

Authors:  Yuko Kondo-Takuma; Masayuki Mizuno; Yo Tsuda; Yuta Madokoro; Kengo Suzuki; Toyohiro Sato; Hiroshi Takase; Yuto Uchida; Ken-Ichi Adachi; Hideki Hida; Cesario V Borlongan; Noriyuki Matsukawa
Journal:  Sci Rep       Date:  2021-11-11       Impact factor: 4.379

7.  Chronic dietary ginseng extract administration ameliorates antioxidant and cholinergic systems in the brains of aged mice.

Authors:  Mi Ra Lee; Jin Yeul Ma; Chang Keun Sung
Journal:  J Ginseng Res       Date:  2017-06-20       Impact factor: 6.060

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.